Journal of the American Society of Hypertension Expands Its Scope and Publication Frequency

New York, January 8, 2013

The Journal of the American Society of Hypertension (JASH), the official journal of the American Society of Hypertension, Inc., is pleased to announce broadening its editorial scope as well as an increase in publication frequency.

As of January 2014, JASH's editorial scope will expand to include clinical research papers and clinical trials in hypertension. In addition, the journal will begin monthly publication. JASH will be the only venue for publication of official ASH papers, including society position papers, white papers, and guidelines.

First launched in 2006, JASH began as a bimonthly publication focusing on basic, applied, and translational research in hypertension. Under the editorial leadership of Myron H. Weinberger, M.D., the journal quickly became recognized as an important contribution to the literature. It is indexed by MEDLINE and has a 2012 Impact Factor of 2.835.

Dr. Weinberger states, "I am proud to continue as Editor-in-Chief of JASH, now designated the sole official journal of the American Society of Hypertension. With the expansion of content to include clinical papers, the journal will serve readers with an interest in the entire spectrum of hypertension, from bench research to clinical application."

# # #

About Journal of the American Society of Hypertension

Journal of the American Society of Hypertension (JASH) publishes peer-reviewed articles on the topics of basic, applied and translational research on blood pressure, hypertension and related cardiovascular disorders and factors; as well as clinical research and clinical trials in hypertension. Original research studies, reviews, hypotheses, editorial commentary and special reports spanning the spectrum of human and experimental animal and tissue research are considered for publication. For more information about JASH, visit

About the Editor
Myron H. Weinberger, M.D., Founding Editor of the Journal of the American Society of Hypertension, is Emeritus Professor of Medicine at the Indiana University School of Medicine and was the Head of the Hypertension Research Center there. He is the recipient of the Tigerstedt Award of the American Society of Hypertension in 1996 and the Page-Bradley Lifetime Achievement Award of the American Heart Association Council for High Blood Pressure Research in 1999 for his contributions to the field of hypertension.

About the American Society of Hypertension, Inc.
The American Society of Hypertension, Inc. (ASH) is the largest organization of hypertension researchers and health care providers in the United States committed to preventing and treating hypertension and its consequences. ASH has a domestic and international membership of basic science and clinical investigators, physicians, physician assistants, nurse practitioners and pharmacists as well as individuals with a scientific interest in hypertension. More information about ASH and its activities can be found at

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Eileen Fournier
+1 212 633 3662